{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:34:56Z","timestamp":1787697296932,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ijrobp.2017.07.023","type":"journal-article","created":{"date-parts":[[2017,7,23]],"date-time":"2017-07-23T02:00:37Z","timestamp":1500775237000},"page":"642-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Radiation Therapy for Optic Pathway and Hypothalamic Low-Grade Gliomas in Children"],"prefix":"10.1016","volume":"99","author":[{"given":"Derek S.","family":"Tsang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin S.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Merchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2017.07.023_bib1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/pbc.20655","article-title":"Optic pathway gliomas","volume":"46","author":"Jahraus","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2217\/cns.12.47","article-title":"Optic pathway gliomas: A review","volume":"2","author":"Fried","year":"2013","journal-title":"CNS Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib3","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cncr.11119","article-title":"Survival and functional outcome of children with hypothalamic\/chiasmatic tumors","volume":"97","author":"Fouladi","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib4","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1750-3639.1997.tb01065.x","article-title":"Optic chiasmatic-hypothalamic glioma","volume":"7","author":"Alshail","year":"1997","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib5","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1200\/JCO.2008.20.9494","article-title":"Phase II trial of conformal radiation therapy for pediatric low-grade glioma","volume":"27","author":"Merchant","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib6","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1200\/JCO.2005.03.8349","article-title":"Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: Substantial risks after radiotherapy","volume":"24","author":"Sharif","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1634\/theoncologist.5-6-477","article-title":"Malignancy in neurofibromatosis type 1","volume":"5","author":"Korf","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib9","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib10","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1200\/JCO.2011.36.6054","article-title":"Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: A report from the Children's Oncology Group","volume":"30","author":"Ater","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3171\/jns.1997.86.5.0747","article-title":"Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas","volume":"86","author":"Packer","year":"1997","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib12","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/neuonc\/nos202","article-title":"Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology","volume":"14","author":"Gnekow","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib13","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/pbc.24958","article-title":"Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database","volume":"61","author":"Bandopadhayay","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1470-2045(00)00019-X","article-title":"Repopulation of tumour cells between cycles of chemotherapy: A neglected factor","volume":"1","author":"Davis","year":"2000","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nrc1650","article-title":"Repopulation of cancer cells during therapy: An important cause of treatment failure","volume":"5","author":"Kim","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.24093","article-title":"Sex is a major determinant of neuronal dysfunction in neurofibromatosis type 1","volume":"75","author":"Diggs-Andrews","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib17","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/pbc.23006","article-title":"Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: Report from the HIT-LGG 1996 trial","volume":"56","author":"von Hornstein","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00381-003-0733-1","article-title":"Low-grade gliomas and leptomeningeal dissemination: A poorly understood phenomenon","volume":"19","author":"Perilongo","year":"2003","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib19","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/cncr.29907","article-title":"Clinical and treatment factors determining long-term outcomes for adult survivors of childhood low-grade glioma: A population-based study","volume":"122","author":"Krishnatry","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib20","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/cncr.29987","article-title":"Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group","volume":"122","author":"Ater","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib21","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1200\/JCO.2003.03.043","article-title":"Progression-free survival in children with optic pathway tumors: Dependence on age and the quality of the response to chemotherapy\u2014Results of the first French prospective study for the French Society of Pediatric Oncology","volume":"21","author":"Laithier","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.wneu.2016.02.042","article-title":"Treatment and outcome in 65 children with optic pathway gliomas","volume":"89","author":"El Beltagy","year":"2016","journal-title":"World Neurosurg"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s004310000531","article-title":"When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre","volume":"159","author":"Grill","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ophtha.2003.06.008","article-title":"Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients","volume":"111","author":"Thiagalingam","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/gcc.22446","article-title":"Confirmation of mutation landscape of NF1-associated malignant peripheral nerve sheath tumors","volume":"56","author":"Sohier","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib26","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2011.10.067","article-title":"Visual outcomes in pediatric optic pathway glioma after conformal radiation therapy","volume":"84","author":"Awdeh","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2014.58.3922","article-title":"BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma","volume":"33","author":"Mistry","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13760-016-0657-7","article-title":"Malignant transformation of low-grade gliomas in patients undergoing adjuvant therapy","volume":"117","author":"Rotta","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib29","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1200\/JCO.2006.06.8213","article-title":"Clinical and molecular characteristics of malignant transformation of low-grade glioma in children","volume":"25","author":"Broniscer","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<8::AID-CNCR3>3.0.CO;2-W","article-title":"Sarcoma arising in irradiated bone: Report of eleven cases. 1948","volume":"82","author":"Cahan","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib31","series-title":"Long-Term Follow-Up Guidelines for Survivors of Childhood, Adolescent and Young Adult Cancers, Version 3.0","year":"2008"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1136\/adc.79.4.334","article-title":"Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era","volume":"79","author":"Cappelli","year":"1998","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0360-3016(97)00359-3","article-title":"Childhood optic chiasm gliomas: Radiographic response following radiotherapy and long-term clinical outcome","volume":"39","author":"Tao","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib34","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijrobp.2004.12.081","article-title":"Fractionated stereotactic radiotherapy of optic pathway gliomas: Tolerance and long-term outcome","volume":"62","author":"Combs","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0360-3016(98)00559-8","article-title":"Fractionated stereotactic radiotherapy (FSRT) for optic glioma","volume":"44","author":"Debus","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib36","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijrobp.2016.10.015","article-title":"Cerebrovascular diseases in childhood cancer survivors: Role of the radiation dose to Willis circle arteries","volume":"97","author":"El-Fayech","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semradonc.2012.11.008","article-title":"Clinical controversies: Proton therapy for pediatric tumors","volume":"23","author":"Merchant","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fonc.2015.00261","article-title":"Secondary malignancy risk following proton radiation therapy","volume":"5","author":"Eaton","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jamaophthalmol.2013.7649","article-title":"Handheld optical coherence tomography during sedation in young children with optic pathway gliomas","volume":"132","author":"Avery","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib40","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.ajo.2015.07.036","article-title":"Longitudinal change of circumpapillary retinal nerve fiber layer thickness in children with optic pathway gliomas","volume":"160","author":"Avery","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib41","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaapos.2010.08.014","article-title":"Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas","volume":"14","author":"Chang","year":"2010","journal-title":"J AAPOS"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib42","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1212\/WNL.0000000000003413","article-title":"Predicting which NF1 optic pathway gliomas will require treatment","volume":"87","author":"Listernick","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib43","first-page":"750","article-title":"Pediatric low-grade gliomas: Implications of the biologic era","volume":"19","author":"Packer","year":"2017","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2017.07.023_bib44","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1177\/0883073809342005","article-title":"Pediatric low-grade gliomas","volume":"24","author":"Sievert","year":"2009","journal-title":"J Child Neurol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617336076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301617336076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T02:01:56Z","timestamp":1602554516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301617336076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0360301617336076"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.023","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation Therapy for Optic Pathway and Hypothalamic Low-Grade Gliomas in Children","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2017.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}